Peter A. Chalk

815 total citations
21 papers, 672 citations indexed

About

Peter A. Chalk is a scholar working on Molecular Biology, Nutrition and Dietetics and Surgery. According to data from OpenAlex, Peter A. Chalk has authored 21 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Nutrition and Dietetics and 8 papers in Surgery. Recurrent topics in Peter A. Chalk's work include Microbial Metabolites in Food Biotechnology (8 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Peter A. Chalk is often cited by papers focused on Microbial Metabolites in Food Biotechnology (8 papers), Helicobacter pylori-related gastroenterology studies (7 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Peter A. Chalk collaborates with scholars based in United Kingdom and United States. Peter A. Chalk's co-authors include Nicky J. Hughes, David J. Kelly, Peter N. Lowe, Christopher L. Clayton, Darerca Owen, Chris L. Clayton, Andrew D. Roberts, R.J. Miles, Robert K. Poole and Trevor Chapman and has published in prestigious journals such as Biochemistry, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Peter A. Chalk

20 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Chalk United Kingdom 15 348 219 105 92 90 21 672
T. Miwa Japan 15 316 0.9× 412 1.9× 164 1.6× 131 1.4× 38 0.4× 40 902
J. Pudles France 15 407 1.2× 64 0.3× 50 0.5× 31 0.3× 129 1.4× 54 717
Alexia Garrigues France 10 391 1.1× 75 0.3× 34 0.3× 30 0.3× 99 1.1× 11 876
Marilyn Harding United Kingdom 15 593 1.7× 284 1.3× 77 0.7× 63 0.7× 67 0.7× 18 1.0k
María Lucas Spain 19 669 1.9× 95 0.4× 73 0.7× 59 0.6× 87 1.0× 36 1.1k
Andreas Nandy Germany 18 455 1.3× 177 0.8× 37 0.4× 94 1.0× 40 0.4× 36 1.3k
E Leone Italy 15 440 1.3× 44 0.2× 25 0.2× 68 0.7× 68 0.8× 36 720
Joseph W.K. Chu Canada 13 341 1.0× 81 0.4× 52 0.5× 62 0.7× 45 0.5× 20 695
Anne‐Brit Otnæss Norway 9 239 0.7× 41 0.2× 140 1.3× 34 0.4× 69 0.8× 15 458
Il-Han Kim South Korea 17 652 1.9× 56 0.3× 95 0.9× 53 0.6× 89 1.0× 43 917

Countries citing papers authored by Peter A. Chalk

Since Specialization
Citations

This map shows the geographic impact of Peter A. Chalk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Chalk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Chalk more than expected).

Fields of papers citing papers by Peter A. Chalk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Chalk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Chalk. The network helps show where Peter A. Chalk may publish in the future.

Co-authorship network of co-authors of Peter A. Chalk

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Chalk. A scholar is included among the top collaborators of Peter A. Chalk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Chalk. Peter A. Chalk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sousa, Ana R., Richard P. Marshall, Sarah Bolton, et al.. (2017). Responsiveness to oral prednisolone in severe asthma is related to the degree of eosinophilic airway inflammation. Clinical & Experimental Allergy. 47(7). 890–899. 22 indexed citations
2.
Robinson, David A., et al.. (2006). Crystal Structures of Helicobacter pylori Type II Dehydroquinase Inhibitor Complexes:  New Directions for Inhibitor Design. Journal of Medicinal Chemistry. 49(4). 1282–1290. 25 indexed citations
3.
Bligh, S. W. Annie, et al.. (2004). Fluorescence Properties of Green Fluorescent Protein FRET Pairs Concatenated with the Small G Protein, Rac, and Its Interacting Domain of the Kinase, p21-Activated Kinase. Assay and Drug Development Technologies. 2(6). 659–673. 3 indexed citations
4.
Chalk, Peter A., et al.. (2003). Use of NMR to Study H. pylori Metabolism. Humana Press eBooks. 8. 69–80.
5.
Evans, Lewis, A.W. Roszak, David A. Robinson, et al.. (2002). Specificity of substrate recognition by type II dehydroquinases as revealed by binding of polyanions1. FEBS Letters. 530(1-3). 24–30. 18 indexed citations
7.
KINSMAN, O. S., Peter A. Chalk, Helen C. Jackson, et al.. (1998). Isolation and Characterisation of an Antifungal Antibiotic (GR135402) with Protein Synthesis Inhibition.. The Journal of Antibiotics. 51(1). 41–49. 39 indexed citations
8.
Owen, Darerca, et al.. (1998). Delineation of the Cdc42/Rac-Binding Domain of p21-Activated Kinase. Biochemistry. 37(21). 7885–7891. 120 indexed citations
9.
KINSMAN, O. S., Peter A. Chalk, Helen C. Jackson, et al.. (1998). ChemInform Abstract: Isolation and Characterization of an Antifungal Antibiotic (GR135402) with Protein Synthesis Inhibition.. ChemInform. 29(25). 2 indexed citations
10.
Chalk, Peter A., et al.. (1997). Interaction of PAR with Rac: Determination of a minimum binding domain on PAK. Biochemical Society Transactions. 25(3). 509S–509S. 4 indexed citations
11.
Chapman, Trevor, et al.. (1996). The respiratory chain ofHelicobacter pylori: identification of cytochromes and the effects of oxygen on cytochrome and menaquinone levels. FEMS Microbiology Letters. 138(1). 59–64. 40 indexed citations
12.
Bottomley, Joanna, Christopher L. Clayton, Peter A. Chalk, & Colin Kleanthous. (1996). Cloning, sequencing, expression, purification and preliminary characterization of a type II dehydroquinase from Helicobacter pylori. Biochemical Journal. 319(2). 559–565. 27 indexed citations
13.
Chang, Hangil, et al.. (1995). Kinetics of substrate oxidation by whole cells and cell membranes of. FEMS Microbiology Letters. 129(1). 33–38. 25 indexed citations
14.
Hughes, Nicky J., Peter A. Chalk, Christopher L. Clayton, & David J. Kelly. (1995). Identification of carboxylation enzymes and characterization of a novel four-subunit pyruvate:flavodoxin oxidoreductase from Helicobacter pylori. Journal of Bacteriology. 177(14). 3953–3959. 98 indexed citations
15.
Chalk, Peter A., et al.. (1995). Kinetics of substrate oxidation by whole cells and cell membranes ofHelicobacter pylori. FEMS Microbiology Letters. 129(1). 34–38. 19 indexed citations
16.
Chalk, Peter A., et al.. (1994). Metabolism of pyruvate and glucose by intact cells of Helicobacter pylori studied by 13C NMR spectroscopy. Microbiology. 140(8). 2085–2092. 51 indexed citations
17.
Chalk, Peter A., et al.. (1991). Efficient translation of synthetic and natural mRNAs in an mRNA-dependent cell-free system from the dimorphic fungus Candida albicans. Journal of General Microbiology. 137(4). 851–857. 6 indexed citations
18.
Sheridan, Rose, Colin Ratledge, & Peter A. Chalk. (1990). Pathways to acetyl-CoA formation inCandida albicans. FEMS Microbiology Letters. 69(1-2). 165–169. 14 indexed citations
19.
Chalk, Peter A., et al.. (1983). Hepatic mitochondrial fatty acid oxidation during the perinatal period in the rat. International Journal of Biochemistry. 15(4). 531–538. 15 indexed citations
20.
Chalk, Peter A. & E. Bailey. (1979). Changes in the ion content of milk during lactation in the rat. Comparative Biochemistry and Physiology Part A Physiology. 63(4). 619–625. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026